Results 221 to 230 of about 32,098 (325)

Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial

open access: yesAllergy, EarlyView.
This emulated target trial investigated the risk of developing chronic respiratory diseases (COPD, asthma, and ILD) associated with live zoster vaccination using a nationwide, population‐based cohort of individuals aged ≥ 50 years in South Korea. Live zoster vaccination significantly reduced the risk of COPD, asthma, and ILD, and reduced hospital ...
Tae Hyeon Kim   +10 more
wiley   +1 more source

Distinct Roles of IL‐4, IL‐13, and IL‐22 in Human Skin Barrier Dysfunction and Atopic Dermatitis

open access: yesAllergy, EarlyView.
This study reports the distinct effects of IL‐4, IL‐13, and IL‐22 on bio‐stabilized human skin with intact barriers and immune cells. IL‐4, IL‐13, and IL‐22 upregulate inflammatory mediators, disrupt skin barrier integrity, and reciprocally modulate IL‐4Rα and IL‐22Rα1 receptors.
Paolo D'Avino   +12 more
wiley   +1 more source

Obesity: Next game changer of allergic airway diseases? [PDF]

open access: yesClin Transl Med
Li W, Marx N, Yang Q, Fang D, Zhang Y.
europepmc   +1 more source

Cellular Stress, Inflammation and Barrier Damage in Gut Epithelial Cells Caused by Aspartame

open access: yesAllergy, EarlyView.
This study shows that aspartame, at dietary‐relevant doses, induces cytotoxicity, cellular distress associated with endoplasmic reticulum stress, oxidative stress, DNA replication and repair mechanism disturbance culminating in epithelial barrier damage.
Yagiz Pat   +16 more
wiley   +1 more source

Immunological Status of Saliva in Children with Asthma by Disease Severity. [PDF]

open access: yesInt J Clin Pediatr Dent
Leshchuk S, Hakami Z, Vishwanathaiah S.
europepmc   +1 more source

Nutraceuticals Against Oxidative Stress in Allergic Diseases. [PDF]

open access: yesBiomolecules
Di Salvo M   +4 more
europepmc   +1 more source

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

open access: yesAllergy, EarlyView.
The Allergic Rhinitis and its Impact on Asthma (ARIA) group is working on the 2024–2025 update of its guidelines for the management of allergic rhinitis (ARIA 2024–2025). The ARIA 2024–2025‐EAACI guidelines will follow GRADE methodology and will incorporate evidence from different sources, including systematic reviews and meta‐analyses, mHealth data ...
Jean Bousquet   +230 more
wiley   +1 more source

Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

open access: yesAllergy, EarlyView.
ABSTRACT Background Allergic rhinitis (AR) impacts quality of life, work and school productivity. Over the last years, an important body of evidence resulting from mHealth data has led to a better understanding of AR. Such advances have motivated an EAACI‐endorsed update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines (ARIA 2024 ...
Bernardo Sousa‐Pinto   +252 more
wiley   +1 more source

Home - About - Disclaimer - Privacy